A study comparing a new, higher-dose nasal spray for opioid overdoses to the standard dose found no increase in survival rates but more side effects. The 8-milligram naloxone spray, approved two years ...
NSYS Therapeutics' SUBSYS™, which uses an Aptar Pharma Sublingual Unit-Dose Spray (UDS) device, has been launched in the USA for breakthrough cancer pain in patients with cancer who are 18 years of ...
A new, higher-dose nasal spray for reversing opioid overdoses did not save more lives than the previous standard dose, but it did cause more vomiting and other side effects, researchers wrote in a ...
U.S. regulators on Friday approved the first high-dose nasal spray for reversing opioid overdoses. The Food and Drug Administration approved Hikma Pharmaceuticals’ Kloxxado, a spray containing 8 ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results